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The presence of surfactant in amniotic fluid has
been demonstrated by the shake method [1].
Its quantitative determination is used for an in-
trauterine diagnosis of lung maturity.
On the other hand, since WEINER [6] reported
about the "Hemostatic activity of atomiotic fluid",
the thromboplastic effect of phospholipids has
been high-lighted especially in the obstetric field.
In order to study this effect of the amniotic
fluid, we followed gestation by weekly determi-
nation of recalcification time and partial thrombo-
plastin time (PTT) and compared these results
with those of the shake method.
l Material and methods
In 40 pregnancies we collected amniotic fluid
samples via the vagina or by transabdominal punc-
ture, using asilicon treated syringe. Approximately
10 ml were collected and centrifuged for 5 minutes
at 1000 rpm. The supernatant was then used for
investigations.
With these samples the following determinations
were performed:
1. Recalcification time.
2. Partial thromboplastin time.
3. Platelet aggregation.
4. Shake test.
l. l Recalcification time
To l/2partof human controlplasma(ORTHo),
1/2 part human amniotic fluid was added and
after incubation for 2 minutes in a water bath
maintained at 37°C, l part 1/40 M CaCl2 was
added. By using a coagulometer (SCHNITGER
und GROSS, West-Germany.) the clotting time
was measured.
As control to l part of human control plasma,
l part of 1/40 M CaCl2 was added.
1.2 Partial thromboplastin time (P.T.T.)
To 0.1 ml plasma, 0.1 ml active cephaloplastin
(ÜADE) and after 2 min 0.1 ml 1/40 M CaCl2
were added and the clotting time was measured
using a coagulometer at +37°C.
l .3 Platelet aggregation.
Platelet aggregation after ADP addition was
observed with an automatic recorder (RiKEN,
Tokyo, Japan.)connectedwith an aggregation-
meter from EVANS (Great Britain.).
For this investigation to 0.5ml of P.R.P.
(platelet rieh plasma) 0.1 ml of 1. l O"6 M ADP
was added.
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Fig. 1. Recalcification-time of
a) normal plasma
b) normal plasma + amniotic fluid after the 30th gestatio-
nal week.
1.4 Shaketest , r
Lung function was tested in the usual manner
by the shakingmethodaccordingtoCLEMENTS
e ta l f l j .
2 Results
2.1 Recalcification time: In all of the 15 investi-
gated pregnancies after the 30 th week, a
shortening of the recelcification time of
amniotic fluid with Standard plasma was ob-
served, whereas prior to the 30th week no
shortening was seen (Fig. 3).
2.2 Partial thromboplastin time: Amniotic fluid
exerted a shortening of the partial thrombo-
plastin time of mixture of Standard plasma
with amniotic fluid after the 30th gestational
week.
In early pregnancy amniotic fluid had only
little effect (Fig. 2). Before the 30th gesta-
tional week a mixture of 1/4 amniotic fluid +
3/4 Standard plasma had a coagulation time
of 47 sec whereas amniotic of 1/2 amniotic
fluid + 1/2 Standard plasma clotted within 41
seconds. After the 30th week those mixtures
had clotting times of 33 sec and 26 sec.












Fig. 2. Partial thromboplastin time of mixtures of Standard
plasma and amniotic fluid before and after the 30th
gestational week.
2.3 Platelet aggregation of amniotic fluid after
the 30thweekcaused disagregation of platelets
agglutinated by ADP in only 3 £ases.
The remaining 15 samples did not cause dis-
aggregation (Fig. 4.).
2.4 The results of shake test is shown Fig. 6.
3 Discussion
The surfactant factor has received considerable
attention s a substance which is associated with
the degree of maturation of the fetal hing, and
due to the possibility that the surfactant factor
itself may activate the blood coagulation System.
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amniot ic f l u i d
Fig. 3. Recalcification-time of Standard plasma after the addition of amniotic fluid during different weeks of pregnancy.
Fig. 4. Platelet aggiegation with ADP.
left: normal plasma. disaggregation can be seen.
right: normal plasma + amniotic fluid. (38 week) disaggregation does not occur.
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Fig. 6. The results of the CLEMENTS titer.
Regarding this, TAYLOR et al. [3,4] reported that
the surface active lipoprotein which he extracted
from lung tissue homogenate plays a role in the
mechanism.
Further, COURTNEY [2] compared the amniotic
fluid of normal pregnancies with those with fetal
death in the Uterus (Tab. L).
As may be clearly seen in Jab. I, in cases of fetal
death in the Uterus mixtures of amniotic fluid with
normal plasma or with Factor VII deficient plasma
show a remarkable lengthening of recalcification
time.
The explanation could be given according to
COURTNEY (Fig. 7.). The changes in the coagula-
tion and fibrinolytic System exerted by the am-
niotic fluid are ässociäted with the thromboplastic
effect which is öriginated partially by phospho-
lipids.
In this study, the thromboplastic effect of amniotic
fluid after the 30th week of pregnancy is shown
by a shortening of recalcification time and partial
thromböplastin time.
For partial thromböplastin time substances that
play the main role in accelerating the clotting
process are phospholipids.
By the shaking method according to CLEMENTS et
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Fig. 7. The possible action of normal and IUD (Intrau-
terine-death) amniotic fluid on blood coagulation.
(CORTNEY [2])
Tab. L Recalcification-time (COURTNEY [2])
Amniotic fluid Normal plasma plasma deficient in
Factor VII Factor VIII Factor IX Factor X
I U D 1
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appears in amniotic fluid around the 30th week of
pregnancy.
As can be seen in Fig. 6 the so-called CLEMENTS
titer [l] gives the same results äs our recalcification
time and partial thromboplastin time.
Thus the so-called surfactant seems to have en-
hancing effect on the blood coagulation. Whether
this substance is actually -palmitoyl lecithin or
not, must be determined in the future. The detec-
tion of the thromboplastic effect of amniotic fluid
by coagulation assays can replace the shaking
method because it gives the same results.
Further, it is an advantage of this method that the
recording can be done with a coagulometer or an
aggregation-meter in a semi-quantitative analysis
(Fig. 2).
According to our results around the 30th week of
gestation should be the borderline for the rise of
phospholipids in the amniotic fluid.
They may be detected by the effect they exert on
the partial thromboplastin time. Thus, the assay
outlined in this paper provides an effective diagno-
stic tool for the early detection of surfactants
essential for the lung function of newborn infants.
Summary
Pulmonary hyaline membrane disease in newborn infants
is considered an abnormality in the alveolar lining layer.
Quantitative analysis of this surfactant is necessary
for the intrauterine diagnosis of lung maturity of the
fetus.
The presence of surfactant in amniotic fluid has been
demonstrated by the shaking method [1]. But it is also
well knowen that amniotic fluid has a thromboplastic
effect [3, 6].
In order to compaie the correlation between the shaking
method and the thromboplastic effect of the amniotic
fluid, recalcification time and partial thromboplastin time
were measured with and without amniotic fluid using an
aggregation-meter.
In each of 15 cases, a shortening of these times was
recorded aftei the addition of amniotic fluid after the
30th week of pregnancy.
In all cases the addition of amniotic fluid resulting in
shortening these times.
Surfactant seems to have enhancing effect on the co-
agulation. These results demonstrate the presence of
surfactant in amniotic fluid in agreement with the results
of the shaking method. Although these methods are of
limited Utility äs quantitative assays for surfactant, they
are of sufficient accuracy and of great value foi clinical
diagnosis.
Keywords: Partial-thromboplastin-time, shaking method, surfactant.
Zusammenfassung
Probleme der Blutgerinnung und Fibrinolyse beim Neuge-
borenen.
II. Thromboplastischer Effekt des Fruchtwassers und seine
Beziehungen zui Lungenreife.
Beim hyalinen Membransyndrom des Neugeborenen
kommt es zu pathologischen Entwicklungen der Alveolen.
Da die Stabilität der Alveolen weitgehend durch den Ge-
halt an Phospholipiden, speziell der Lezithine bestimmt
wird (Surfaktant) und das Fruchtwasser mit der Lunge
intraamnial kommuniziert, kann durch eine Surfaktant-
Bestimmung im Fruchtwasser auf die Lungenreife ge-
schlossen werden.
Hierzu dient der Schaumtest nach CLEMENTS [1]. Ander-
seits ist bekannt, daß Fruchtwasser einen Thromboplastin-
Effekt, verursacht durch die Phospholipide, hat. Um fest-
zustellen, ob eine Korrelation zwischen dem Schaumtest
und dem Thromboplastin-Effekt des Fruchtwasser besteht,
wurden die folgenden beschriebenen Experimente durch-
geführt.
a) Recalzifizierungszeit mit und ohne Zusatz von Frucht-
wasser.
b) Partielle Thromboplastinzeit mit und ohne Frucht-
wasser unter Verwendung eines Agglutinationsmeß-
gerätes.
Bei beiden Experimenten wurde in allen 15 untersuchten
Fällen eine Zeitverkürzung festgestellt, wenn das Frucht-
wasser nach der 30. Woche entnommen worden war.
Fruchtwasser vor der 30 Schwangerschaftswoche ergab
keine Zeitverkürzung. Es ergibt sich hier also die gleiche
Tendens wie beim Schaumtest.
Die Ergebnisse zeigen, daß die angewandten Methoden,
obschon nur halbquantitativ, für die klinische Diagnostik
durchaus verwendbar sind.
Schlüsselwörter: Partielle Thromboplastonzeit, Schütteltest, Surfaktant.
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Resume
Nouveaux problemes de coagulation sanguine et de
fibrinolyse en neonatalogie
II. Effet thromboplastique du liquide amniotique et ses
rappoits avec la maturite pulmonaiie
Le syndrome de membrane hyaline pulmonaire chez les
nouveauxnes conduit a un developpement pathologique
des alveoles.
Or, la stabilite des alveoles etant largement assuree par la
teneur en phospholipides, specialement en lecithine,
(surfactant), et le liquide amniotique communiquant avec
le poumon de fagon intraamniale, on en deduit qu'ü est
possible de determiner la maturite pulmonaire par une
analyse quantitative du surfactant dans le liquide
amniotique («shaking method» de CLEMENTS et al.
[1]).
On sait, par ailleurs, que le liquide amniotique a un effet
thromboplastic cause par les phospholipides [3, 6], Afin
donc d'etablir s^il existe une correlation entre la «shaking
method» et l'effet de thromboplastine du liquide
amniotique, on a mesure a l'aide d'un enregistreur
d'agglütination le temps de recalcification et le temps
partiel de thromboplastine avec et sans liquide amniotique.
Dans les deux series d'examens on a observe sans exception
pour les 15 cas un raccourcissement des temps apres
addition de liquide amniotique preleve apres la 30eme
semaine de grossesse, ce qui confirme les resultats en-
registres par la «shaking method» (presence dans le
liquide amniotique de surfactant qui accroit l'effet de
coagulation).
Bien qüe ces methodes ne soient que d'une utilite limitee
pour determiner la quantite de surfactant, eUes sont
suffisamment precises pour servir au diagnostic clinique.
Mots-cles: «Shaking method», surfactant, temps partiel de thromboplastine.
Acknowledgement: The helpful advices of Prof. GRAEFF (Munich), Dr. KARGES and Dr. HEIMBURGER (Marburg)
are greatfully acknowledged. This research was supported by the Alexander von HUMBOLDT foundation in Bonn.
Bibliography
[1] CLEMENTS, J. A.: Assessment of risk of the respir-
atory distress syndrome by a rapid test for surfactant
in amniotic Huid. New Engl. J. Med. 286 (1972) 1077
[2JCOURTNEY, L. D., M. ALLINGTON: Effect of
amniotic fluid on blood coagulation. Brit. J.
Haematol. 22 (1972) 353
[3] TAYLOR, F., M. B. ABRAMS: Inhibition of clot
lysis by a surface active lipoprotein from lung and
Inhibition of its surface activity by fibrinogen.
Physiologist 7 (1964) 269
[4] TAYLOR, F., M. B. ABRAMS: Effect of surface
active lipoprotein on clotting and fibrinolysis and
of fibrinogen surface active lipoprotein. With a hypo-
thesis on the pathogenesis of pulmonary atelectasis
and hyaline membrane in respiratory distress syndrome
of the newborn. Amer. J. Medf 40 (1966) 346
[5] WAKE, N., s. SUZUKI, K. YOSHIAKI, s. MATSUDA:
The study of amniotic surfactant. Japanese Journal of
perinatal medicine 4 (1974) l
[6] WEINER, A. E., D.E. REID, C. C. ROBY: Hemostastic
activity of amniotic fluid. Science, 110 (1949) 190
Received April 19, 1976. Accepted September l, 1976.
Dr. Shigenori Suzuki
Frauenklinik der Universität Hokkaido
(Hokudai Byoin)
Kita 14-jo, Nishi 5-chome, Kita-Ku
Sapporo 060 Japan
J. Perinat. Med. 4(1976)
